Martine Rothblatt

2014

In 2014, Martine Rothblatt earned a total compensation of $33.2M as Chairman and Chief Executive Officer at United Therapeutics, a 13% decrease compared to previous year.

Compensation breakdown

Change in Pension Value and Nonqualified Deferred Compensation Earnings$1,633,033
Non-Equity Incentive Plan$1,073,981
Option Awards$29,460,128
Salary$1,024,524
Other$23,263
Total$33,214,929

Rothblatt received $29.5M in option awards, accounting for 88.70% of the total pay in 2014.

Rothblatt also received $1.6M of change in pension value and nonqualified deferred compensation earnings, $1.1M in non-equity incentive plan, $1M in salary and $23.3K in other compensation.

Rankings

In 2014, Martine Rothblatt's compensation ranked 40th out of 12,981 executive pay records tracked by us. In other words, Rothblatt earned more than 99.7% of all executives tracked by us in 2014.

ClassificationRankingPercentile
All
40
out of 12,981
100th
Manufacturing
Division
13
out of 4,954
100th
Chemicals And Allied Products
Major group
7
out of 1,653
100th
Drugs
Industry group
7
out of 1,327
100th
Pharmaceutical Preparations
Industry
7
out of 1,017
99th
Source: SEC filing on April 28, 2017.

Rothblatt's colleagues

We found three more compensation records of executives who worked with Martine Rothblatt at United Therapeutics in 2014.

2014

Roger Jeffs

United Therapeutics

Chief Executive Officer

2014

John Ferrari

United Therapeutics

Chief Financial Officer

2014

Paul Mahon

United Therapeutics

General Counsel

News

In-depth

You may also like